SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-135615
Filing Date
2020-05-07
Accepted
2020-05-07 07:42:00
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d898108d10q.htm 10-Q 802690
2 EX-31.1 d898108dex311.htm EX-31.1 6562
3 EX-31.2 d898108dex312.htm EX-31.2 6501
4 EX-32.1 d898108dex321.htm EX-32.1 5663
  Complete submission text file 0001193125-20-135615.txt   3184419

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mgta-20200331.xml EX-101.INS 515147
6 XBRL TAXONOMY EXTENSION SCHEMA mgta-20200331.xsd EX-101.SCH 26460
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20200331_cal.xml EX-101.CAL 29932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20200331_def.xml EX-101.DEF 209596
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20200331_lab.xml EX-101.LAB 262602
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20200331_pre.xml EX-101.PRE 229391
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 20854608
SIC: 2834 Pharmaceutical Preparations